Quarterly report · Q3
4885.TEDINET S100T9HF
Period2023-06-01 → 2024-02-29
Filed2024-04-12
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 38
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.5bn | 2023-06-01 → 2024-02-29 | Standalone | Net sales |
| Revenue | ¥6.3bn | 2022-06-01 → 2023-05-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥4.6bn | 2022-06-01 → 2023-02-28 | Standalone | Net sales |
| Operating income | ¥252m | 2023-06-01 → 2024-02-29 | Standalone | Operating income |
| Operating income | ¥325m | 2022-06-01 → 2023-02-28 | Standalone | Operating income |
| Ordinary income | ¥246m | 2023-06-01 → 2024-02-29 | Standalone | Ordinary income |
| Ordinary income | ¥351m | 2022-06-01 → 2023-05-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥309m | 2022-06-01 → 2023-02-28 | Standalone | Ordinary income |
| Profit before tax | ¥287m | 2023-06-01 → 2024-02-29 | Standalone | Income before income taxes |
| Profit before tax | ¥309m | 2022-06-01 → 2023-02-28 | Standalone | Income before income taxes |
| Net income | ¥191m | 2023-06-01 → 2024-02-29 | Standalone | Profit loss |
| Net income | ¥256m | 2022-06-01 → 2023-05-31 | Standalone | Net income loss (5-year summary) |
| Net income | ¥230m | 2022-06-01 → 2023-02-28 | Standalone | Profit loss |
| Total assets | ¥5.3bn | at 2024-02-29 | Standalone | Assets |
| Total assets | ¥4.9bn | at 2023-05-31 | Standalone | Assets |
| Total assets | ¥5.0bn | at 2023-02-28 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥3.2bn | at 2024-02-29 | Standalone | Liabilities |
| Total liabilities | ¥3.0bn | at 2023-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.1bn | at 2024-02-29 | Standalone | Net assets |
| Net assets / equity | ¥1.9bn | at 2023-05-31 | Standalone | Net assets |
| Net assets / equity | ¥1.9bn | at 2023-02-28 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥954m | at 2024-02-29 | Standalone | Cash and deposits |
| Cash and deposits | ¥853m | at 2023-05-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥48.2 | 2023-06-01 → 2024-02-29 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥24.52 | 2023-12-01 → 2024-02-29d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥67.94 | 2022-06-01 → 2023-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥61.46 | 2022-06-01 → 2023-02-28 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.53 | 2022-12-01 → 2023-02-28d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥47.27 | 2023-06-01 → 2024-02-29 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥64.12 | 2022-06-01 → 2023-05-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥58.55 | 2022-06-01 → 2023-02-28 | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥19 | 2022-06-01 → 2023-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Equity ratio | 39.9% | at 2024-02-29 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.7% | at 2023-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.5% | at 2023-02-28 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 4,095,500 | at 2024-02-29 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2023-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2023-02-28 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥1.6bn |
| jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥1.6bn |
| jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segment | segment profit | 2023-06-01 → 2024-02-29 | −¥22m |
| jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥563m |
| jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥563m |
| jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segment | segment profit | 2023-06-01 → 2024-02-29 | −¥40m |
| jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥2.3bn |
| jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥2.3bn |
| jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segment | segment profit | 2023-06-01 → 2024-02-29 | ¥314m |
| —segment total | revenue | 2023-06-01 → 2024-02-29 | ¥4.5bn |
| —segment total | revenue external | 2023-06-01 → 2024-02-29 | ¥4.5bn |
| —segment total | segment profit | 2023-06-01 → 2024-02-29 | ¥252m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-06-01 → 2024-02-29 | ¥4.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-06-01 → 2024-02-29 | ¥4.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-06-01 → 2024-02-29 | ¥252m |
| jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥1.5bn |
| jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥1.5bn |
| jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segment | segment profit | 2022-06-01 → 2023-02-28 | −¥25m |
| jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥528m |
| jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥528m |
| jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segment | segment profit | 2022-06-01 → 2023-02-28 | −¥75m |
| jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥2.6bn |
| jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥2.6bn |
| jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥426m |
| —segment total | revenue | 2022-06-01 → 2023-02-28 | ¥4.6bn |
| —segment total | revenue external | 2022-06-01 → 2023-02-28 | ¥4.6bn |
| —segment total | segment profit | 2022-06-01 → 2023-02-28 | ¥325m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2023-02-28 | ¥4.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2023-02-28 | ¥4.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2023-02-28 | ¥325m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 369
| Item | Context | Value | Unit |
|---|---|---|---|
| Foreign exchange losses noe | CurrentYTDDuration_NonConsolidatedMember | - | JPY |
| Other noe | Prior1YTDDuration_NonConsolidatedMember | 826000 | JPY |
| Other noe | CurrentYTDDuration_NonConsolidatedMember | 1121000 | JPY |
| Non operating expenses | Prior1YTDDuration_NonConsolidatedMember | 26379000 | JPY |
| Non operating expenses | CurrentYTDDuration_NonConsolidatedMember | 14457000 | JPY |
| Ordinary income | Prior1YTDDuration_NonConsolidatedMember | 308576000 | JPY |
| Ordinary income | CurrentYTDDuration_NonConsolidatedMember | 245988000 | JPY |
| Gain on sales of noncurrent assets ei | Prior1YTDDuration_NonConsolidatedMember | 9000 | JPY |
| Gain on sales of noncurrent assets ei | CurrentYTDDuration_NonConsolidatedMember | 7254000 | JPY |
| Gain on sales of investment securities ei | Prior1YTDDuration_NonConsolidatedMember | - | JPY |
| Gain on sales of investment securities ei | CurrentYTDDuration_NonConsolidatedMember | 998000 | JPY |
| Surrender value of insurance ei | Prior1YTDDuration_NonConsolidatedMember | - | JPY |
| Surrender value of insurance ei | CurrentYTDDuration_NonConsolidatedMember | 32949000 | JPY |
| Extraordinary income | Prior1YTDDuration_NonConsolidatedMember | 9000 | JPY |
| Extraordinary income | CurrentYTDDuration_NonConsolidatedMember | 41203000 | JPY |
| Loss on retirement of noncurrent assets el | Prior1YTDDuration_NonConsolidatedMember | 0 | JPY |
| Loss on retirement of noncurrent assets el | CurrentYTDDuration_NonConsolidatedMember | 133000 | JPY |
| Extraordinary loss | Prior1YTDDuration_NonConsolidatedMember | 0 | JPY |
| Extraordinary loss | CurrentYTDDuration_NonConsolidatedMember | 133000 | JPY |
| Income before income taxes | Prior1YTDDuration_NonConsolidatedMember | 308586000 | JPY |
| Income before income taxes | CurrentYTDDuration_NonConsolidatedMember | 287058000 | JPY |
| Income taxes current | Prior1YTDDuration_NonConsolidatedMember | 27990000 | JPY |
| Income taxes current | CurrentYTDDuration_NonConsolidatedMember | 22273000 | JPY |
| Income taxes deferred | Prior1YTDDuration_NonConsolidatedMember | 50420000 | JPY |
| Income taxes deferred | CurrentYTDDuration_NonConsolidatedMember | 74222000 | JPY |
| Income taxes | Prior1YTDDuration_NonConsolidatedMember | 78410000 | JPY |
| Income taxes | CurrentYTDDuration_NonConsolidatedMember | 96495000 | JPY |
| Profit loss | Prior1YTDDuration_NonConsolidatedMember | 230175000 | JPY |
| Profit loss | CurrentYTDDuration_NonConsolidatedMember | 190563000 | JPY |
| Revenues from external customers | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000PharmaceuticalBusinessReportableSegmentMember | 2601224000 | JPY |
| Revenues from external customers | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000HealthyFoodBusinessReportableSegmentMember | 528184000 | JPY |
| Revenues from external customers | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000ChemicalProductsBusinessReportableSegmentMember | 1495196000 | JPY |
| Revenues from external customers | Prior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember | 4624606000 | JPY |
| Revenues from external customers | Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember | 4624606000 | JPY |
| Revenues from external customers | Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember | - | JPY |
| Revenues from external customers | Prior1YTDDuration_NonConsolidatedMember | 4624606000 | JPY |
| Transactions with other segments | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000PharmaceuticalBusinessReportableSegmentMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000HealthyFoodBusinessReportableSegmentMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000ChemicalProductsBusinessReportableSegmentMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_NonConsolidatedMember | - | JPY |
| Net sales | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000PharmaceuticalBusinessReportableSegmentMember | 2601224000 | JPY |
| Net sales | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000HealthyFoodBusinessReportableSegmentMember | 528184000 | JPY |
| Net sales | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000ChemicalProductsBusinessReportableSegmentMember | 1495196000 | JPY |
| Net sales | Prior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember | 4624606000 | JPY |
| Net sales | Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember | 4624606000 | JPY |
| Net sales | Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember | - | JPY |
| Net sales | Prior1YTDDuration_NonConsolidatedMember | 4624606000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |